Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025

SELL
N/A
-81,715 Reduced 69.46%
35,936 $306,000
Q1 2025

May 14, 2025

BUY
N/A
52,132 Added 79.57%
117,651 $1 Million
Q4 2024

Feb 11, 2025

BUY
N/A
23,311 Added 55.23%
65,519 $559,000
Q3 2024

Nov 13, 2024

BUY
N/A
42,208 New
42,208 $360,000
Q4 2023

Feb 14, 2024

BUY
N/A
49,959 New
49,959 $437 Million

Others Institutions Holding CMPS

About COMPASS Pathways plc


  • Ticker CMPS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 42,522,400
  • Market Cap $363M
  • Description
  • COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...
More about CMPS
Track This Portfolio

Track Entry Point Capital, LLC Portfolio

Follow Entry Point Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Entry Point Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Entry Point Capital, LLC with notifications on news.